Unilever back in court over pro.activ cholesterol claims


- Last updated on GMT

Unilever back in court over pro.activ cholesterol claims

Related tags Food safety authority Cardiovascular disease European union

Food giant Unilever appeared in a Hamburg court today to defend use of expert statements that its plant sterol-based Becel pro.activ did not have any side effects such as bloodstream plaque levels in healthy people.

According to Unilever and challenger Foodwatch, the judge indicated Unilever (and any similar entity) should be able to quote expert opinions in such missives, something Foodwatch said set a dangerous precedent in food communications while placing public health in danger.

“We are disappointed. The judge says it is a freedom of information issue but this is a food safety issue,” ​Foodwatch’s Oliver Huizinga told us. Foodwatch wants pro.activ and similar products like Raisio’s plant stanol-based Benecol range reclassified as medicines and says on-packet warnings stating the products are not suitable for people without cholesterol issues are insufficient. “They are sold with the other margarines and this is not acceptable."

The food sector watchdog and consumer rights advocate took Unilever to court in 2012 after Unilever issued a press release​ quoting food scientists (Dr Hans-Ulrich Klör and Dr Eberhard Windler) saying there was from a scientific perspective "no indication of side effects"​ such as atherosclerotic plaques from consuming pro.activ. Foodwatch lost that case and so appealed.

“Nothing has changed..."

“We expect that the appeals court will follow this verdict which it has already indicated during today’s hearing,”​ Unilever said of its cholesterol-lowering products.

“Nothing has changed, as far as we are concerned: We stand by our product. Becel pro.activ is a foodstuff that is assessed as safe and which actively lowers cholesterol levels and can thus make a contribution to reducing one of the cardiovascular disease risk factors.”

It added: “Over 70% of the German population aged over 45 have a cholesterol level that is too high. This is a risk factor for cardiovascular disease, of which 345.000 people died last year alone in Germany. That is what we should be thinking about again now instead of fighting in the courts.”

Plant sterols and stanols were backed by the European Food Safety Authority (EFSA) and European Union to make cholesterol reducing claims in 2009, some of the first approvals under the nascent EU nutrition and health claims regulation (NHCR). The claim was refined last year so that products sold in the EU's 28 member states had to carry warnings that they were not suitable for healthy people.

Olivier Huizinga

Huizinga said post-2008 data and scientific reviews should be reviewed by EFSA, something the Parma, Italy-based agency has indicated is not “a high priority”.

Actors like the German Federal Institute for Risk Assessment (BfR) in 2008 called for a plant sterol-stanol safety review due to research that showed potential cardiovascular problems may be linked to overconsumption of sterol margarines, milks and breads by children and others that did not have raised cholesterol levels.

The French Food Safety Authority (ANSES) last year questioned​ the products' efficacy and safety, while not completely refuting the EU backing.

Huizinga accused the German government of “protecting the food industry“ ​ by not doing more to enforce food safety.

The global market for sterol-stanol based products is estimated to be worth about €2.5bn. Claims are approved in Norway, Switzerland, the US, Australia, New Zealand, South Africa, Brazil, Israel, Iceland, Japan and Canada.

The Hamburg court is expected to deliver its verdict on September 1.

Related news

Show more

Related products

show more

Optimize Nutritional Value with DuraLipo™

Optimize Nutritional Value with DuraLipo™

Content provided by INNOBIO Corporation Limited | 02-May-2024 | White Paper

INNOBIO's DuraLipo™ products encapsulates active ingredients within phospholipids, forming a genuine phospholipid bilayer structure.

Women's Health Before, During & Beyond Menopause

Women's Health Before, During & Beyond Menopause

Content provided by Akay Bioactives | 26-Apr-2024 | White Paper

Discover the science of FenuSmart®, a unique fenugreek seed extract that merges ancient wisdom with modern clinical research to support women's health...

Related suppliers

1 comment

Unilever Pro.activ set

Posted by Dr. Sunil Kumar Banerjee,

The Unilever product should be good as is expected to bio-compete with cholesterol thereby reducing the cholesterol level in the blood. In addition, it is likely to be beneficial for men suffering from prostate problems.

Report abuse

Follow us


View more